{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:14:09Z","timestamp":1753892049965,"version":"3.41.2"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Extensive lymphatic malformations in the head and neck region pose a significant risk due to potential airway compression, and conventional treatment modalities have proven largely ineffective. Currently, systemic administration of sirolimus is recognized as a promising therapeutic approach for complex lymphatic malformations. Nevertheless, the appropriate dosage, optimal blood concentration, efficacy, and safety profile of sirolimus in pediatric patients remain inadequately characterized. In this report, we present a clinical case involving a 3-month-old male infant diagnosed with tongue lymphatic malformation, treated with sirolimus. It is noteworthy that the trough concentration of sirolimus is influenced by both genetic and non-genetic factors, including physiological and pathological conditions, as well as drug-food and drug-drug interactions in pediatric patients. Despite the sirolimus concentration below the target range during treatment, a reduction in tumor size was observed. Additionally, based on the patient's medical history, adjustments in medication, and liver function assessments, the pharmacist has excluded the likelihood of sirolimus-induced hepatotoxicity. This case underscores the safety and efficacy of sirolimus in managing extensive lymphatic malformations of the head and neck in infants. Regular monitoring and analysis of variations in sirolimus blood concentrations, coupled with long-term follow-up observations, are essential for enhancing treatment efficacy and minimizing toxicity risks.<\/jats:p>","DOI":"10.3389\/fped.2025.1587330","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:11:33Z","timestamp":1745467893000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Application of sirolimus in an infant presenting with a life-threatening lymphatic malformation of the head and neck: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Shuying","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1542\/peds.2014-3673","article-title":"Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies","volume":"136","author":"Wassef","year":"2015","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/jcm8030371","article-title":"The application of virtual reality for preoperative planning of lymphovenous anastomosis in a patient with a complex lymphatic malformation","volume":"8","author":"Giacalone","year":"2019","journal-title":"J Clin Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/lrb.2013.0001","article-title":"Localization of lymphatic malformations of the neck","volume":"11","author":"Wiegand","year":"2013","journal-title":"Lymphat Res Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1001\/archoto.2009.131","article-title":"Microcystic lymphatic malformations of the tongue: diagnosis, classification, and treatment","volume":"135","author":"Wiegand","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1007\/s00405-022-07378-8","article-title":"Efficacy of sirolimus in children with lymphatic malformations of the head and neck","volume":"279","author":"Wiegand","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/hed.21552","article-title":"Sclerotherapy of lymphangiomas of the head and neck","volume":"33","author":"Wiegand","year":"2011","journal-title":"Head Neck"},{"key":"B7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/1573396309666131209210751","article-title":"A review of the management of lymphangiomas","volume":"10","author":"Ha","year":"2014","journal-title":"Curr Pediatr Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00428-008-0611-z","article-title":"Pathogenesis of lymphangiomas","volume":"453","author":"Wiegand","year":"2008","journal-title":"Virchows Arch"},{"key":"B9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1089\/lrb.2018.0068","article-title":"Oral sirolimus: an option in the management of neonates with life-threatening upper airway lymphatic malformations","volume":"17","author":"Triana","year":"2019","journal-title":"Lymphat Res Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/pin.12913","article-title":"Analysis of mtor pathway expression in lymphatic malformation and related diseases","volume":"70","author":"Hori","year":"2020","journal-title":"Pathol Int"},{"key":"B11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1089\/lrb.2017.0062","article-title":"Treatment of lymphatic malformations with the mtor inhibitor sirolimus: a systematic review","volume":"16","author":"Wiegand","year":"2018","journal-title":"Lymphat Res Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e26470","DOI":"10.1002\/pbc.26470","article-title":"Developmental pharmacokinetics of sirolimus: implications for precision dosing in neonates and infants with complicated vascular anomalies","volume":"64","author":"Mizuno","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1016\/j.ijporl.2015.10.031","article-title":"Airway response to sirolimus therapy for the treatment of complex pediatric lymphatic malformations","volume":"79","author":"Alemi","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jdcr.2016.05.019","article-title":"Treatment of cystic hygroma in a young infant through multidisciplinary approach involving sirolimus, sclerotherapy, and debulking surgery","volume":"2","author":"Azouz","year":"2016","journal-title":"JAAD Case Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3969\/j.issn.1673-0364.2016.02.001","article-title":"Cssva guidelines for vascular anomalies 2016","volume":"12","year":"2016","journal-title":"J Tissue Eng Reconstr Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3969\/j.issn.1673-0364.2019.05.001","article-title":"Cssva guidelines for vascular anomalies 2019","volume":"15","year":"2019","journal-title":"J Tissue Eng Reconstr Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijporl.2017.11.034","article-title":"Sirolimus for management of complex vascular anomalies\u2014a proposed dosing regimen for very young infants","volume":"105","author":"Czechowicz","year":"2018","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1016\/j.ejps.2017.05.037","article-title":"Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies","author":"Mizuno","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2058738420934936","DOI":"10.1177\/2058738420934936","article-title":"The first study in pediatric: population pharmacokinetics of sirolimus and its application in Chinese children with immune cytopenia","volume":"34","author":"Cheng","year":"2020","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/hep.23437","article-title":"Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma","volume":"51","author":"Toso","year":"2010","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/FTD.0000000000000415","article-title":"Effect of Cyp3a4 and Cyp3a5 genetic polymorphisms on the pharmacokinetics of sirolimus in healthy Chinese volunteers","volume":"39","author":"Zhang","year":"2017","journal-title":"Ther Drug Monit"},{"key":"B22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/cpdd.96","article-title":"Steady-state pharmacokinetics of sirolimus in stable adult Chinese renal transplant patients","volume":"3","author":"Wang","year":"2014","journal-title":"Clin Pharmacol Drug Dev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/bdd.1881","article-title":"Abcb1 haplotype influences the sirolimus dose requirements in Chinese renal transplant recipients","volume":"35","author":"Lee","year":"2014","journal-title":"Biopharm Drug Dispos"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1038\/psp.2012.18","article-title":"Nonlinear population pharmacokinetics of sirolimus in patients with advanced cancer","volume":"1","author":"Wu","year":"2012","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40262-015-0340-9","article-title":"Pharmacokinetics, pharmacodynamics, and pharmacogenomics of immunosuppressants in allogeneic hematopoietic cell transplantation: part II","volume":"55","author":"McCune","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ejps.2018.12.004","article-title":"Significant effect of infection and food intake on sirolimus pharmacokinetics and exposure in pediatric patients with acute lymphoblastic leukemia","volume":"128","author":"Mizuno","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1055\/s-0034-1376264","article-title":"Medical therapy for pediatric vascular anomalies","volume":"28","author":"Margolin","year":"2014","journal-title":"Semin Plast Surg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1007\/s12325-021-01758-y","article-title":"Patients with congenital low-flow vascular malformation treated with low dose sirolimus","volume":"38","author":"Harbers","year":"2021","journal-title":"Adv Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3969\/j.issn.1672-3384.2021.09.015","article-title":"Sirolimus-induced adverse reactions in children: a literature analysis","volume":"19","author":"Li","year":"2021","journal-title":"Clin Med J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.13407\/j.cnki.jpp.1672-108X.2022.01.003","article-title":"Blood concentration monitoring and clinical application of sirolimus in children","volume":"28","author":"Wang","year":"2022","journal-title":"J Pediatr Pharm"},{"key":"B31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3760\/cma.j.cn501113-20230419-00176-1","article-title":"Chinese guideline for diagnosis and management of drug-induced liver injury (2023 version)","volume":"31","year":"2023","journal-title":"Chin J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13023-023-02740-3","article-title":"Oral antibiotic prophylaxis for infection in patients with vascular anomalies receiving sirolimus treatment: a multicenter retrospective study","volume":"18","author":"Qiu","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"S425","DOI":"10.1542\/peds.2016-2919","article-title":"A case report of 2 sirolimus-related deaths among infants with kaposiform hemangioendotheliomas","volume":"141","author":"Ying","year":"2018","journal-title":"Pediatrics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e28936","DOI":"10.1002\/pbc.28936","article-title":"Severe adverse events during sirolimus \u201coff-label\u201d therapy for vascular anomalies","volume":"68","author":"Rossler","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children","volume":"57","author":"Hammill","year":"2011","journal-title":"Pediatr Blood Cancer"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1587330\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:11:39Z","timestamp":1745467899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1587330\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":35,"alternative-id":["10.3389\/fped.2025.1587330"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1587330","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"article-number":"1587330"}}